The largest database of trusted experimental protocols

15 protocols using hla dr

1

Isolation and Characterization of hBM-MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, total BM aspirate was directly seeded at a concentration of 50,000 total nucleated cells/cm2 in T75 plastic flask in Minimum Essential Medium Alpha (α-MEM) supplemented with 1% GlutagroTM, 10% Fetal Bovine Serum (FBS) and 1% Penicillin/Streptomycin (Pen/Strep) and incubated at 37 °C in an atmosphere of 5% CO2 and 95% relative humidity [33 (link)]. After 72 h, nonadherent cells were removed by medium change and the remaining adherent cells were then fed twice weekly thereafter with new medium. On day 14, colonies of adherent hBM-MSCs were detached and reseeded at 4000 cells/cm2 in the same culture conditions. Once cell cultures reached 70–80% confluence (7–8 days from the previous passage), cells were detached using 0.05% trypsin-0.53 mM Ethylenediaminetetraacetic acid (EDTA) and washed with 1× of phosphate buffered saline (PBS) (Corning Cellgro, Manassas, VA, USA), counted using Trypan Blue (Sigma-Aldrich, Milan, Italy) and subcultured at a concentration of 4 × 103 cells/cm2. At passage 2, cells were used experimentally.
Flow cytometry analysis was performed on hBM-MSCs obtained at passage 2; cells were positive for CD90, CD105, CD73 and negative for CD14, CD34, CD45, HLA-DR expression (Beckman Coulter, Brea, CA, USA) (data not shown) [34 (link)].
+ Open protocol
+ Expand
2

Endocytic receptor and immune cell analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endocytic receptors were stained using the following antibodies: CD206/MR (eBioscience), DC-SIGN, CD36 (both from BD Biosciences), SR-A1 (R&D Systems), LOX-1 (BioLegend), and SR-B1 (Novus Biologicals). DC and T cell phenotypes were examined using antibodies against the following markers: HLA-ABC (BioLegend), CD206, CD40, CD80, CD83, IL-2 (BD Biosciences), CD4, CD8, TNF-α, IL-2, and HLA-DR (Beckman Coulter). Data were acquired with an Accuri C6 cytometer (BD Biosciences) and analyzed using CFlow Plus software.
+ Open protocol
+ Expand
3

Immunophenotypic Characterization of MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
BM, AT, WJ and FSK-MSCs from three different donors were activated or not with 25 µg/ml of Poly(I:C) and 1 μg/ml of Poly(I:C)/LyoVec for 24 h and examined for the expression of different hematopoietic, endothelial and stromal cell surface markers using fluorochrome-conjugated monoclonal antibodies: CD34 (Becton, Dickinson, and Company, Franklin Lakes, NJ, USA); CD45 (Miltenyi Biotec, Leiden, the Netherlands), CD73, CD105 (Ancell Corporation, Bayport, MN, USA), CD90 (R&D Systems, Minneapolis, MN, UK), CD14, CD19 and HLA-DR (Beckman Coulter, Indianapolis, IN, USA).
+ Open protocol
+ Expand
4

Phenotypic Characterization of MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
About 1.105 MSCs were incubated in PBS + 2% HSA, and 0.5% polyvalent human immunoglobulins (LFB) for 20 min at 4°C; then incubated with antibodies at a saturating concentration for 20 min at 4°C: MSC CD90, HLA-ABC, HLA-DR, B7-H1, and CD54 (all from Beckman Coulter). Then, MSCs were washed with PBS and immediately acquired using Navios cytometer (Beckman Coulter). Data were analyzed on Kaluza software (Beckman Coulter). Concentration of VEGF was determined using a sandwich-enzyme linked immunosorbent assay technique (R&D system) according to the manufacturer’s recommendations. VEGF was determined in MSC supernatant of naive and HYP-primed cells.
+ Open protocol
+ Expand
5

Comprehensive Immunophenotyping of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For flow cytometry, PBMC samples were thawed in a 37°C water bath and resuspended in DMEM:F12 media (Fisher 11320–033). Cells were then pelleted (1000 rpm x 5 min) and washed twice using DPBS. Pellets were resuspended in live/dead solution (Fisher L34961) on ice for 20 minutes. Samples were then washed twice with FACS buffer and stained with extracellular antibodies consisting of CD14 (BD 561391), CD16 (BD 562874 and BD561394), CD11b (BD 561887), HLA-DR (BD 339194), CD3 (BD 558124 or BD 557757), CD20 (BD 560734), CD4 (BD 347327), CD8 (BD 335787), NKG2A (Beckman Coulter A60797), CD1c (Biolegend 331506), and CD123 (BD 560826) on ice for 30 min. Stained samples were washed twice with FACS buffer and fixed and permeabilized using BD Cytofix/Cytoperm (BD554714) for 20 min on ice. Samples were washed twice using 1x BD Cytoperm buffer (BD554714) 500 g x 4 min and resuspended in intracellular antibody cocktail consisting of CD38 (BD 560676) and Ki-67 (BD 558616) for 20 minutes on ice. After washing, samples were fixed and inactivated using 4% (w/v) paraformaldehyde, run on a BD LSRII, and analyzed using FlowJo 10.5.0.
+ Open protocol
+ Expand
6

Flow Cytometry Immunophenotyping of Hematopoietic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometric immunophenotyping was performed with 100 µL of bone marrow aspirate or peripheral blood by using SSC/CD45 gating. The flow cytometry screen included several lymphoid and myeloid markers, including HLA-DR, CD56, CD16, CD5, CD33, CD13, CD117, CD34, CD19, CD3, and CD45 (all Beckman Coulter, Brea). After staining the samples with these antibodies, red blood cell lysis (8.29 g NH4Cl, 1 g KHCO3, 0.037 g ethylenediaminetetraacetic with 1000 mL Aqua dest) was performed and samples were washed twice with 1× phosphate-buffered saline (PBS) (Sigma-Aldrich, Taufkirchen, Germany). Cells were resuspended in fluorescence-activated cell sorting (FACS) buffer (containing PBS and bovine serum albumin) and measured by a Flow cytometer (NAVIOS; Beckman Coulter). If the leukemic blast population expressed more than 20% of an antigen, it was considered positive. Stored data
were analyzed by Navios software (Beckman Coulter).
+ Open protocol
+ Expand
7

Flow Cytometric Immunophenotyping Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometric immunophenotyping experiments were performed using CD2, CD3, CD5, CD7, CD10, CD11b, CD13, CD14, CD19, CD20, CD33, CD34, CD36, CD38, CD41b, CD56, CD61, CD64, CD71, CD117, cMPO, and HLA‐DR antibodies purchased from Beckman Coulter (Brea, CA), or Becton Dickinson (Franklin Lakes, NJ). Acquisition was carried out on a Navios 10‐color flow cytometer (Beckman Coulter), and blasts were identified according to the expression of myeloid, B lymphoid, T lymphoid, monocytic, erythroid, and megakaryocytic markers.
+ Open protocol
+ Expand
8

Immunophenotyping of Leukemic Blasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunophenotyping was performed with bone marrow aspirates or peripheral blood at initial diagnosis following standard diagnostic procedures as described previously.17 (link) In brief, screening was performed by using different markers, including: CD45, CD19, CD34, IgM, kappa, lambda, CD10, CD22, CD65, CD20, CD24, CD79a, CD15, CD3, TdT, HLA-DR (all Beckman Coulter). Antibody solutions were utilized as recommended by the manufacturer. Following red blood cell lysis and two subsequent washing steps, cells were resuspended in PBS containing 1% BSA. Cells were analyzed using a Navios Flow Cytometer (Beckman Coulter) and data was analyzed using Navios software version 1.3. Samples containing >80% leukemic blasts were chosen for cell sorting.
+ Open protocol
+ Expand
9

Comprehensive Immune Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood was utilized for flow cytometry to determine the frequencies and phenotype of T cells, NK cells, NK/T cells, Treg and MDSC. Blood was processed and stained automatically per manufacturer’s instructions on a TQ-PrepPlus2 (Beckman Coulter), and stained with CD3, CD16, CD56, CD69, CCR7, CD4, CD25, CD39, lineage, HLA-DR, CD14, CD11b, CD33 (Beckman Coulter) and/or intracellular FoxP3 (eBioscience), and analyzed on an FC500 flow cytometer using CXP v2.1 (Beckman Coulter) software.
+ Open protocol
+ Expand
10

Immunophenotyping of Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Since differentiation status of stem cells is tightly connected to cell cycle, we analyzed the eMSCs population for the expression of the main surface markers of human mesenchymal stem cells. For immunophenotypic analysis of CD markers a single cell suspension was obtained using 0.05% trypsin and EDTA (Invitrogen, USA). Cells (1 × 106/ml) were resuspended in PBS solution containing 5% fetal bovine serum. The cells were treated with FITC or phycoerythrin-labeled antibodies to CD34, CD44, CD105, HLA-DR (Beckman Coulter), CD73 (BD Biosciences) and CD90 (Chemicon) and assayed by flow cytometry. Cell fluorescence was measured using CytoFLEX (Beckman Coulter, USA) flow cytometer. CD-phenotyping of cells was conducted in parallel with other experiments described in this article. We found that all cells of the analyzed population express CD 73, CD 90, and CD 105; and do not express CD 34 and HLA-DR (Supplementary Fig. S2). These results are in accordance with the minimal criteria for defining multipotent mesenchymal stromal cells stated by the International Society for Cellular Therapy27 (link). According to the expression profile of surface CD markers, the analyzed population is homogeneous. It is important to note that 100% of the analyzed cells express CD90 marker of stemness, i.e. the cells used in our study have the status of stem, non-differentiated cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!